Atrial natriuretic peptide in human urine

Area of Science:

• Biochemistry
• Clinical Chemistry
• Endocrinology

Background:

• Atrial natriuretic peptide (ANP) plays a role in cardiovascular regulation.
• Accurate measurement of urinary ANP is crucial for understanding its physiological and pathological roles.
• Existing methods may lack the sensitivity or practicality for routine clinical use.

Purpose of the Study:

• To establish a highly sensitive radioimmunoassay for measuring atrial natriuretic peptide (ANP) concentration in urine.
• To evaluate the clinical utility of this assay in healthy individuals and patients with congestive heart failure.
• To assess the stability and ease of measurement of urinary ANP using the developed assay.

Main Methods:

• Development and validation of a radioimmunoassay for urinary ANP.
• Measurement of ANP concentration and fractional excretion in urine samples.
• Analysis of ANP levels in healthy controls and patients with congestive heart failure before and after treatment.

Main Results:

• The developed radioimmunoassay demonstrated high sensitivity and stability of urinary ANP at 4°C.
• Average ANP excretion in 65 healthy individuals was 25.0 ± 1.4 ng/day, with a fractional excretion of 0.7 ± 0.05%.
• In 14 congestive heart failure patients, average ANP excretion was significantly higher (119.2 ± 29.4 ng/day) and decreased to 53.3 ± 11.0 ng/day after successful treatment.

Conclusions:

• A sensitive and reliable radioimmunoassay for urinary ANP has been successfully established.
• Urinary ANP levels are significantly elevated in patients with congestive heart failure.
• The assay is clinically useful for assessing ANP excretion and monitoring treatment response in heart failure.